Printer Friendly
The Free Library
4,489,688 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

"Musculo-Skeletal-Disorders - Osteoarthritis Drug Pipeline Report" Gives In-Depth Insight into Current Pipelines.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c63585) has announced the addition of Musculo-Skeletal-Disorders - Osteoarthritis Drug Pipeline Report to their offering.

"Musculo-Skeletal-Disorders - Osteoarthritis Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of osteoarthritis drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.

- Keep track of your competitors and partners by better understanding their product pipeline.

- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.

- Maintain a critical competitive advantage.

RECENT HIGHLIGHTS AND CHANGES

--Recent Highlights and Changes

UPCOMING PATENT EXPIRES BY THERAPY AREA

Osteoarthritis Pipeline Overview

--% of Projects (By Phase of Development)

--No. of Projects by Phase of Development

--Marketed Products Vs. Pipeline Products

Company Overview - Pipeline Projects

--Company Overview - Pipeline Projects

--Legend

--Top 20 companies in late stage Osteoarthritis Projects

--Top 20 companies in early stage Osteoarthritis Projects

Full Pipeline View

--Phase II Pipeline View

--Phase III Pipeline View

--Pending Approval Pipeline View

For more information visit http://www.researchandmarkets.com/reports/c63585

Source: Life Science Analytics

COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 24, 2007
Words:371
Previous Article:New Report Examines Health Plan Trends in the State of Washington.
Next Article:Westinghouse and Shaw Sign Historic Contracts to Provide Four AP1000 Nuclear Power Plants in China.



Related Articles
MY hero from Georgia.(GLSEN's 2006 Respect Award)(Brief Article)
Lauderdale breaks through for Ems.(Sports)(The third baseman goes 4-for-4, and Canham comes through with a grand slam in a 9-7 victory over Vancouver)
Defy the Decider.(Editorials)(If Bush vetoes SCHIP, Republicans must override)(Editorial)
FOR NO D'OH, TICKET WINNERS IN FOR FUN.(Entertainment)(Springfield plans to give away more than 200 tickets to a July 26 screening)
$12 COTTON CANDY ASIDE, CIRCUS STILL THE 'GREATEST'.(LA.COM)
NO 'CASHBACK,' PLEASE.(LA.COM)
'HAIRSPRAY' HOLDS UP VERY NICELY.(LA.COM)
RADIATING ENERGY SCI-FI THRILLER ABOUT DYING SUN A BRIGHT ADDITION TO FILMMAKER BOYLE'S BODY OF WORK.(LA.COM)
A parity plan for dual eligibles: the Home and Community Services Copayment Equity Act of 2007.(ASSISTED LIVING review)
Brain attack: progress is slow in finding better ischemic-stroke therapies.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles